Bixiye
QP73-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Bempedoic Acid PA with QL
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Natiijooyinka Raadinta
Soo bandhiga 2481 - 2490 ee natiijooyinka 4139
Bixiye
QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP71-20 MHCP Pharmacy Benefit Update: Pharmacy Benefit Exclusion for Phesgo™, Uplizna™, and Zepzelca™
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP75-20 Commercial Pharmacy Benefit Exclusion for Aralast®NP, Eylea®, Glassia®, Lucentis®, Prolastin®-C, and UpliznaTM
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
QP70-20 In-Home Test Kits 2020 Program Details for Medicare Advantage and SecureBlue Members
Taariikhda barnaamijka Dhaqangalayso Agosto 12, 2020
Bixiye
P61-20 Site of Service for Selected Outpatient Procedures: XI-03 Medical Policy Update
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020
Bixiye
P28R1-20 Update: Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda barnaamijka Dhaqangalayso Agosto 03, 2020